Preferred Label : pasireotide;

MeSH note : a somatostatin analog;

CISMeF synonym : SOM-230;

MeSH synonym : cyclo((4R)-4-(2-aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-d-tryptophyl-L-lysyl-4-o-benzyl-L-tyrosyl-L-phenylalanyl-);

MeSH hyponym : SOM 230; SOM230;

Is substance : O;

UNII : 98H1T17066;

InChIKey : VMZMNAABQBOLAK-DBILLSOUSA-N;

Details


Main resources

You can consult :


https://www.has-sante.fr/portail/jcms/c_2908487/fr/signifor
2019
true
false
France
French
evaluation of the transparency committee
acromegaly
pituitary acth hypersecretion
pasireotide
orphan drug production
pasireotide
adult
somatostatin
injections, intramuscular
aged
insurance, health, reimbursement
treatment outcome
risk management
product surveillance, postmarketing

---
https://www.has-sante.fr/portail/jcms/c_2839029/fr/signifor
2018
false
false
France
French
evaluation of the transparency committee
acromegaly
pituitary acth hypersecretion
pasireotide
pasireotide
orphan drug production
pasireotide
adult
somatostatin
injections, intramuscular
aged
insurance, health, reimbursement
treatment outcome
risk management
product surveillance, postmarketing

---
http://www.has-sante.fr/portail/jcms/c_2034331/fr/signifor
http://www.has-sante.fr/portail/jcms/c_2034331/fr/signifor-pasireotide-analogue-de-la-somatostatine
2015
false
France
French
evaluation of the transparency committee
acromegaly
guidelines for drug use
pasireotide
pasireotide
orphan drug production
pasireotide
adult
somatostatin
injections, intramuscular
aged
insurance, health, reimbursement
treatment outcome
risk management
product surveillance, postmarketing

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00269
2013
false
false
false
Canada
Pasireotide 0.3mg/mL injection solution (product)
Pasireotide 0.6mg/mL injection solution (product)
Pasireotide 0.9mg/mL injection solution (product)
pasireotide
pasireotide
drug information
somatostatin
somatostatin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68990053
2013
summary of product characteristics
pasireotide
injections

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67724733
2013
summary of product characteristics
injections
pasireotide

---
http://www.has-sante.fr/portail/jcms/c_1320044/signifor-pasireotide-analogue-de-la-somatostatine
http://www.has-sante.fr/portail/jcms/c_1320024/signifor-18072012-synthese
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-08/signifor_18072012_ct12258.pdf
http://www.has-sante.fr/portail/jcms/c_1284805/signifor
2012
false
France
French
corticosteroid therapy
pasireotide
pasireotide
pasireotide
somatostatin
pituitary acth hypersecretion
drug approval
evaluation of the transparency committee
guidelines for drug use
orphan drug production
insurance, health, reimbursement
adult
injections, subcutaneous
aged
treatment outcome
clinical trials, phase iii as topic
hydrocortisone
risk management

---
https://www.ema.europa.eu/medicines/human/EPAR/Signifor
2012
United Kingdom
English
French
summary of product characteristics
package leaflet
drug evaluation
syndication feed
pasireotide
pasireotide
pasireotide
drug approval
treatment outcome
injections, subcutaneous
orphan drug production
somatostatin
adult
aged
drug interactions
pregnancy
breast feeding
fertility
receptors, somatostatin
somatostatin receptor 5
drug evaluation, preclinical
pituitary acth hypersecretion
self administration

---
Nous contacter.
26/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.